Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

• (A Little) Clarity on Convalescent Plasma for Covid-19.10 passages
• 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.37 passages
• 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.1 passage
• 24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk.1 passage
• A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.1 passage
• A Bivalent Omicron-Containing Booster Vaccine against Covid-19.34 passages
• A Case Series of Children with Acute Hepatitis and Human Adenovirus Infection.1 passage
• A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.1 passage
• A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.27 passages
• A Comparison of Peripherally Inserted Central Catheter Materials.1 passage
• A Crossover Trial of Hospital-Wide Lactated Ringer's Solution versus Normal Saline.1 passage
• A Dual-Chamber Leadless Pacemaker.1 passage
• A Human Pleiotropic Multiorgan Condition Caused by Deficient Wnt Secretion.1 passage
• A Large, Simple Trial Leading to Complex Questions.6 passages
• A Microbiota-Directed Food Intervention for Undernourished Children.22 passages
• A Modular Communicative Leadless Pacing-Defibrillator System.1 passage
• A Monoclonal Antibody for Malaria Prevention.1 passage
• A Monoclonal Antibody to PACAP for Migraine Prevention.1 passage
• A Multicomponent Intervention to Improve Maternal Infection Outcomes.26 passages
• A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.32 passages
• A New Orthonairovirus Associated with Human Febrile Illness.1 passage
• A New Vaccine to Battle Covid-19.6 passages
• A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia.1 passage
• A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.1 passage
• A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia.1 passage
• A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.1 passage
• A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis.1 passage
• A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.1 passage
• A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D.1 passage
• A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy.1 passage
• A Phase 3 Trial of Brepocitinib in Dermatomyositis.1 passage
• A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.1 passage
• A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.1 passage
• A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus.1 passage
• A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.1 passage
• A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.1 passage
• A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.1 passage
• A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina.36 passages
• A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.1 passage
• A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.1 passage
• A Population-Based Study of Genes Previously Implicated in Breast Cancer.1 passage
• A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.28 passages
• A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening.1 passage
• A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.1 passage
• A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery.1 passage
• A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.1 passage
• A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.1 passage
• A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.28 passages
• A Randomized Trial of Drug Route in Out-of-Hospital Cardiac Arrest.23 passages
• A Randomized Trial of Enteral Glutamine for Treatment of Burn Injuries.1 passage
• A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke.1 passage
• A Randomized Trial of Intravenous Amino Acids for Kidney Protection.1 passage
• A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain.32 passages
• A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus.33 passages
• A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion.1 passage
• A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.1 passage
• A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.1 passage
• A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.1 passage
• A Trial of Trimethoprim-Sulfamethoxazole in Pregnancy to Improve Birth Outcomes.1 passage
• AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.1 passage
• AAV9-Mediated Gene Therapy for Infantile-Onset Pompe's Disease.1 passage
• APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer's Disease.1 passage
• APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans.24 passages
• AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis.1 passage
• Abelacimab for Prevention of Venous Thromboembolism.1 passage
• Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.1 passage
• Abortion Safety and Use with Normally Prescribed Mifepristone in Canada.1 passage
• Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.1 passage
• Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.1 passage
• Acquired Osteomalacia Associated with Autoantibodies against PHEX.4 passages
• Acquired Resistance to KRASG12C Inhibition in Cancer.1 passage
• Actionable Genotypes and Their Association with Life Span in Iceland.1 passage
• Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages.3 passages
• Acute Effects of Coffee Consumption on Health among Ambulatory Adults.1 passage
• Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease.1 passage
• Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation.1 passage
• Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.1 passage
• Added Benefit of Covid-19 Vaccination after Previous Infection.7 passages
• Adenoviral Inciting Antigen and Somatic Hypermutation in VITT.28 passages
• Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia.20 passages
• Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.29 passages
• Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke.1 passage
• Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma.1 passage
• Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.1 passage
• Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.1 passage
• Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.1 passage
• Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.1 passage
• Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.1 passage
• Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.25 passages
• Adrenal Aldosterone Synthase Expression Imaging in Primary Aldosteronism.3 passages
• Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex.2 passages
• Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.1 passage
• Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy.1 passage
• Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.1 passage
• Age-Related Macular Degeneration.1 passage
• Aggressive Lymphoma after CD19 CAR T-Cell Therapy.1 passage
• Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis.1 passage
• Air Pollution and Mortality at the Intersection of Race and Social Class.1 passage
• Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.1 passage
• Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.1 passage
• Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours.1 passage
• Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.1 passage
• Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.1 passage
• Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC.1 passage
• An Accurate and Rapidly Calibrating Speech Neuroprosthesis.1 passage
• An Alternate Explanation.1 passage
• An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1.1 passage
• An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II.1 passage
• An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis.1 passage
• Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.1 passage
• Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation.1 passage
• Angiography-Based Physiology to Guide Coronary Revascularization.1 passage
• Angiography-Derived Fractional Flow Reserve to Guide PCI.1 passage
• Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.1 passage
• Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer.1 passage
• Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.1 passage
• Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.4 passages
• Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux.1 passage
• Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection.1 passage
• Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections.1 passage
• Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.4 passages
• Antibody Response to Omicron BA.4-BA.5 Bivalent Booster.4 passages
• Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.5 passages
• Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.5 passages
• Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.22 passages
• Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.1 passage
• Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression.1 passage
• Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation.1 passage
• Apixaban for Extended Treatment of Provoked Venous Thromboembolism.1 passage
• Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.1 passage
• Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.1 passage
• Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency.1 passage
• As-Needed Albuterol-Budesonide in Mild Asthma.1 passage
• Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.1 passage
• Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.1 passage
• Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture.1 passage
• Assessment of a Polygenic Risk Score in Screening for Prostate Cancer.33 passages
• Association between Covid-19 Vaccination and Influenza Vaccination Rates.4 passages
• Association between Wealth and Mortality in the United States and Europe.1 passage
• Association of 2024-2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. Veterans.1 passage
• Association of SARS-CoV-2 Infection during Early Weeks of Gestation with Situs Inversus.3 passages
• Asundexian for Secondary Stroke Prevention.1 passage
• Asundexian versus Apixaban in Patients with Atrial Fibrillation.1 passage
• Atezolizumab for Advanced Alveolar Soft Part Sarcoma.1 passage
• Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer.29 passages
• Atogepant for the Preventive Treatment of Migraine.1 passage
• Atrasentan in Patients with IgA Nephropathy.1 passage
• Autoantibodies Targeting Nephrin in Podocytopathies.1 passage
• Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.1 passage
• Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.1 passage
• Avacopan for the Treatment of ANCA-Associated Vasculitis.1 passage
• Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.1 passage
• Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.1 passage
• Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial.1 passage
• Azithromycin during Routine Well-Infant Visits to Prevent Death.1 passage
• Azithromycin for Preschoolers with Wheezing in the Emergency Department.21 passages
• Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis.1 passage
• Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth.1 passage
• Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.1 passage
• BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection.24 passages
• BNT162b2 Protection against the Omicron Variant in Children and Adolescents.28 passages
• BNT162b2 Vaccine Booster and Mortality Due to Covid-19.29 passages
• BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.21 passages
• BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.4 passages
• BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.3 passages
• BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.26 passages
• BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.5 passages
• BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.1 passage
• Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock.30 passages
• Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults.1 passage
• Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.27 passages
• Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.6 passages
• Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes.1 passage
• Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.27 passages
• Barrett's Esophagus.1 passage
• Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease.1 passage
• Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia.1 passage
• Bedaquiline Activity against Leprosy.2 passages
• Bedaquiline Monotherapy for Multibacillary Leprosy.1 passage
• Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.1 passage
• Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma.1 passage
• Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma.1 passage
• Belzutifan for Advanced Pheochromocytoma or Paraganglioma.1 passage
• Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.1 passage
• Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.1 passage
• Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang Syndrome.1 passage
• Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.1 passage
• Benefits and Risks of Iron Interventions in Infants in Rural Bangladesh.1 passage
• Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.1 passage
• Beta-Blocker Interruption or Continuation after Myocardial Infarction.1 passage
• Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.1 passage
• Beta-Blockers after Myocardial Infarction in Patients without Heart Failure.1 passage
• Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction.1 passage
• Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction.1 passage
• Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia.1 passage
• Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer.1 passage
• Bimekizumab versus Adalimumab in Plaque Psoriasis.1 passage
• Bimekizumab versus Secukinumab in Plaque Psoriasis.1 passage
• Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.1 passage
• Biomarker Changes during 20 Years Preceding Alzheimer's Disease.1 passage
• Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.37 passages
• Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.1 passage
• Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.1 passage
• Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.1 passage
• Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.1 passage
• Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.1 passage
• Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest.1 passage
• Booster Doses and Prioritizing Lives Saved.5 passages
• Borrelia burgdorferi Infection and Erythema Migrans.3 passages
• Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers.1 passage
• Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.3 passages
• Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.1 passage
• Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer.1 passage
• Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.1 passage
• Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors.1 passage
• Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.1 passage
• Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D.1 passage
• Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.1 passage
• Bupropion and Naltrexone in Methamphetamine Use Disorder.1 passage
• Burden of Typhoid and Paratyphoid Fever in India.26 passages
• CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.1 passage
• CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia.1 passage
• CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.1 passage
• CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53.17 passages
• CRISPR-Based Therapy for Hereditary Angioedema.1 passage
• CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.1 passage
• CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia.1 passage
• CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.1 passage
• CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.1 passage
• CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy.1 passage
• CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.1 passage
• CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.1 passage
• CT or Invasive Coronary Angiography in Stable Chest Pain.1 passage
• Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.1 passage
• Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges.28 passages
• Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.1 passage
• Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.1 passage
• Calm before the Storm.4 passages
• Calorie Restriction with or without Time-Restricted Eating in Weight Loss.1 passage
• Cancer Screening after the Adoption of Paid-Sick-Leave Mandates.1 passage
• Cannabis Legalization and Detection of Tetrahydrocannabinol in Injured Drivers.1 passage
• Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.1 passage
• Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.1 passage
• Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.1 passage
• Cardiogenic Shock.1 passage
• Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.1 passage
• Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.1 passage
• Cardiovascular Safety of Testosterone-Replacement Therapy.1 passage
• Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.1 passage
• Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.1 passage
• Case 18-2021: An 81-Year-Old Man with Cough, Fever, and Shortness of Breath.27 passages
• Case 28-2021: A 37-Year-Old Woman with Covid-19 and Suicidal Ideation.28 passages
• Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae.28 passages
• Case 34-2022: A 57-Year-Old Woman with Covid-19 and Delusions.30 passages
• Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.35 passages
• Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.1 passage
• Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia.1 passage
• Cefepime-Taniborbactam in Complicated Urinary Tract Infection.1 passage
• Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia.1 passage
• Celiac Disease.1 passage
• Cemented or Uncemented Hemiarthroplasty for Intracapsular Hip Fracture.1 passage
• Cerebral Amyloid Angiopathy.1 passage
• Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.1 passage
• Cerebral Oximetry Monitoring in Extremely Preterm Infants.1 passage
• Chapare Hemorrhagic Fever and Virus Detection in Rodents in Bolivia in 2019.1 passage
• Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events.1 passage
• Childhood Vaccine Hesitancy.1 passage
• Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.1 passage
• Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.1 passage
• Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.1 passage
• Chronic Traumatic Encephalopathy in the Brains of Military Personnel.1 passage
• Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.1 passage
• Ciprofloxacin versus Aminoglycoside-Ciprofloxacin for Bubonic Plague.23 passages
• Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.1 passage
• Clearance of Driver Mutations after Transplantation for Myelofibrosis.1 passage
• Clesrovimab for Prevention of RSV Disease in Healthy Infants.1 passage
• Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.35 passages
• Clinical Implications of Minipuberty.1 passage
• Clinical Spectrum of Children with Acute Hepatitis of Unknown Cause.1 passage
• Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.1 passage
• Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.1 passage
• Cognition and Memory after Covid-19 in a Large Community Sample.39 passages
• Cognitive Motor Dissociation in Disorders of Consciousness.24 passages
• Colchicine in Acute Myocardial Infarction.1 passage
• Collagenase Injection versus Limited Fasciectomy for Dupuytren's Contracture.35 passages
• Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma.30 passages
• Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies.1 passage
• Common Diseases in Clinical Cohorts - Not Always What They Seem.1 passage
• Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.1 passage
• Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.1 passage
• Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans.22 passages
• Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction.1 passage
• Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.1 passage
• Congenital Hypermetabolism and Uncoupled Oxidative Phosphorylation.21 passages
• Continuation versus Interruption of Oral Anticoagulation during TAVI.1 passage
• Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.29 passages
• Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.6 passages
• Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients.26 passages
• Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.1 passage
• Corynebacterium diphtheriae Outbreak in Migrant Populations in Europe.1 passage
• Covid-19 Boosters - Where from Here?5 passages
• Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.31 passages
• Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes.27 passages
• Covid-19 Vaccination during Pregnancy - Two for the Price of One.6 passages
• Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage.3 passages
• Covid-19 Vaccine Acceptance in California State Prisons.3 passages
• Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.28 passages
• Covid-19 Vaccine Effectiveness and the Test-Negative Design.7 passages
• Covid-19 Vaccine Effectiveness in New York State.29 passages
• Covid-19 Vaccine Protection among Children and Adolescents in Qatar.41 passages
• Covid-19 Vaccines - Immunity, Variants, Boosters.21 passages
• Covid-19 mRNA Vaccines - Six of One, Half a Dozen of the Other.7 passages
• Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).4 passages
• Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.1 passage
• Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation.1 passage
• Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex.1 passage
• DB-OTO Gene Therapy for Inherited Deafness.1 passage
• Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations.1 passage
• Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.31 passages
• Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.1 passage
• Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.1 passage
• Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation.1 passage
• Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.1 passage
• Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.1 passage
• Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.1 passage
• Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.1 passage
• Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.1 passage
• Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer.1 passage
• Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.1 passage
• Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy.1 passage
• Decline in Pathogenic Antibodies over Time in VITT.4 passages
• Decolonization in Nursing Homes to Prevent Infection and Hospitalization.1 passage
• Decompression with or without Fusion in Degenerative Lumbar Spondylolisthesis.1 passage
• Decompressive Craniectomy versus Craniotomy for Acute Subdural Hematoma.1 passage
• Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia.1 passage
• Deferring Arterial Catheterization in Critically Ill Patients with Shock.1 passage
• Defibrillation Strategies for Refractory Ventricular Fibrillation.1 passage
• Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color.3 passages
• Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.4 passages
• Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy.1 passage
• Dengue Suppression by Male Wolbachia-Infected Mosquitoes.1 passage
• Dersimelagon in Erythropoietic Protoporphyrias.1 passage
• Detection of Marburg Virus Disease in Guinea.4 passages
• Developmental Consequences of Defective ATG7-Mediated Autophagy in Humans.1 passage
• Dexamethasone and Surgical-Site Infection.1 passage
• Dexamethasone in Hospitalized Patients with Covid-19.25 passages
• Dexamethasone versus Surgery for Chronic Subdural Hematoma.1 passage
• Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis.1 passage
• Diagnostic Complexity in Monoclonal Gammopathy of Thrombotic Significance.3 passages
• Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines.5 passages
• Diffuse Large B-Cell Lymphoma.1 passage
• Digital Technology for Diabetes.1 passage
• Digital Twin-Guided Ablation for Ventricular Tachycardia.4 passages
• Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.1 passage
• Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease.1 passage
• Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.1 passage
• Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer.1 passage
• Diversity of the National Medical Student Body - Four Decades of Inequities.1 passage
• Does the World Still Need New Covid-19 Vaccines?8 passages
• Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.1 passage
• Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.1 passage
• Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.1 passage
• Donanemab in Early Alzheimer's Disease.1 passage
• Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.1 passage
• Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma.1 passage
• Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.1 passage
• Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease.1 passage
• Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.1 passage
• Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke.1 passage
• Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab.1 passage
• Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.1 passage
• Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.1 passage
• Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.1 passage
• Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.1 passage
• Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.1 passage
• Durability of Bivalent Boosters against Omicron Subvariants.5 passages
• Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.3 passages
• Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.3 passages
• Durability of XBB.1.5 Vaccines against Omicron Subvariants.5 passages
• Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.5 passages
• Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression.1 passage
• Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.1 passage
• Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19.3 passages
• Duration of Device-Based Fever Prevention after Cardiac Arrest.1 passage
• Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.27 passages
• Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.3 passages
• Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.1 passage
• EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge.1 passage
• Early Active Mobilization during Mechanical Ventilation in the ICU.1 passage
• Early Amino Acids in Extremely Preterm Infants and Neurodisability at 2 Years.1 passage
• Early Convalescent Plasma for High-Risk Outpatients with Covid-19.29 passages
• Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial.1 passage
• Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction.1 passage
• Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center.3 passages
• Early Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest.1 passage
• Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.30 passages
• Early Outpatient Treatment for Covid-19 with Convalescent Plasma.38 passages
• Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.28 passages
• Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.1 passage
• Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years.1 passage
• Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke.1 passage
• Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.1 passage
• Early Treatment with Pegylated Interferon Lambda for Covid-19.38 passages
• Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes.1 passage
• Early versus Later Anticoagulation for Stroke with Atrial Fibrillation.1 passage
• Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal.1 passage
• Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination.1 passage
• Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease.17 passages
• Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease.1 passage
• Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.1 passage
• Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A.1 passage
• Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.1 passage
• Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.1 passage
• Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.36 passages
• Effect of Donor Sex on Recipient Mortality in Transfusion.1 passage
• Effect of Early Treatment with Ivermectin among Patients with Covid-19.36 passages
• Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.1 passage
• Effect of Salt Substitution on Cardiovascular Events and Death.1 passage
• Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.4 passages
• Effect of Vaccination on Transmission of SARS-CoV-2.4 passages
• Effect of a Reduced PCV10 Dose Schedule on Pneumococcal Carriage in Vietnam.29 passages
• Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.35 passages
• Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.4 passages
• Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.6 passages
• Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.28 passages
• Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.5 passages
• Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.5 passages
• Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age.22 passages
• Effectiveness of Bivalent Boosters against Severe Omicron Infection.5 passages
• Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.30 passages
• Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.39 passages
• Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina.27 passages
• Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron.6 passages
• Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans.6 passages
• Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.1 passage
• Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.21 passages
• Effectiveness of an Inactivated SARS-CoV-2 Vaccine.9 passages
• Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.28 passages
• Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.4 passages
• Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.4 passages
• Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19.26 passages
• Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison.5 passages
• Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.5 passages
• Effects of Cooking with Liquefied Petroleum Gas or Biomass on Stunting in Infants.1 passage
• Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.37 passages
• Effects of Radiotherapy in Normal Tissue.1 passage
• Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.1 passage
• Effects of Vaccination and Previous Infection on Omicron Infections in Children.5 passages
• Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant.3 passages
• Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.1 passage
• Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.26 passages
• Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.1 passage
• Efficacy and Safety of Donidalorsen for Hereditary Angioedema.1 passage
• Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.1 passage
• Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.1 passage
• Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.32 passages
• Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.1 passage
• Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus.1 passage
• Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.1 passage
• Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.36 passages
• Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults.1 passage
• Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.1 passage
• Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults.1 passage
• Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.1 passage
• Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults.36 passages
• Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.34 passages
• Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.6 passages
• Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants.5 passages
• Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.4 passages
• Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75.5 passages
• Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.5 passages
• Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza.1 passage
• Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.31 passages
• Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant.4 passages
• Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue.29 passages
• Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.32 passages
• Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.1 passage
• Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.5 passages
• Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.36 passages
• Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.25 passages
• Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine.1 passage
• Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.1 passage
• Electronic Nicotine-Delivery Systems for Smoking Cessation.1 passage
• Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer.1 passage
• Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.1 passage
• Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma.1 passage
• Emodepside for Trichuris trichiura and Hookworm Infection.1 passage
• Empagliflozin after Acute Myocardial Infarction.1 passage
• Empagliflozin in Heart Failure with a Preserved Ejection Fraction.1 passage
• Empagliflozin in Patients with Chronic Kidney Disease.26 passages
• Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer.32 passages
• Endovascular Therapy for Acute Stroke with a Large Ischemic Region.1 passage
• Endovascular Therapy for Post-Thrombotic Syndrome - A Randomized Trial.31 passages
• Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion.1 passage
• Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels.1 passage
• Endovascular Treatment of Medium-Vessel-Occlusion Strokes.1 passage
• Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion.1 passage
• Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.1 passage
• Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma.1 passage
• Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia.1 passage
• Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure.1 passage
• Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.1 passage
• Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.1 passage
• Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.1 passage
• Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.1 passage
• European Study of Prostate Cancer Screening - 23-Year Follow-up.1 passage
• Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy.5 passages
• Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.39 passages
• Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.35 passages
• Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.32 passages
• Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age.37 passages
• Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.33 passages
• Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.1 passage
• Evidence of Artemisinin-Resistant Malaria in Africa.1 passage
• Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.1 passage
• Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda.1 passage
• Evolving Epidemiology of Mpox in Africa in 2024.1 passage
• Exagamglogene Autotemcel for Severe Sickle Cell Disease.1 passage
• Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia.1 passage
• Expansion of tetM-Carrying Neisseria gonorrhoeae in the United States, 2018-2024.3 passages
• Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus.1 passage
• Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.1 passage
• Extracorporeal Life Support in Infarct-Related Cardiogenic Shock.1 passage
• FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.1 passage
• False Positive Covid-19 Rapid Antigen Tests.1 passage
• Familial Clonal Hematopoiesis in a Long Telomere Syndrome.1 passage
• Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency.1 passage
• Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis.3 passages
• Ferric Carboxymaltose in Heart Failure with Iron Deficiency.1 passage
• Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study.1 passage
• Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.1 passage
• Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.41 passages
• Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B.1 passage
• Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.1 passage
• Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.1 passage
• Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.35 passages
• Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.1 passage
• Finerenone in Type 1 Diabetes and Chronic Kidney Disease.1 passage
• Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.1 passage
• First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer.1 passage
• First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC.1 passage
• First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate.1 passage
• First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.1 passage
• First-Line Zongertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer.1 passage
• Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.1 passage
• Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation.1 passage
• Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial.1 passage
• Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.1 passage
• Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.1 passage
• Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.1 passage
• Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.24 passages
• Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial.25 passages
• Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI.1 passage
• Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.1 passage
• Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age.1 passage
• Fremanezumab in Children and Adolescents with Episodic Migraine.1 passage
• Functional Dyspepsia.1 passage
• Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.1 passage
• GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma.1 passage
• GLP-1 Receptor Agonists.1 passage
• GPRC5D-Targeted CAR T Cells for Myeloma.1 passage
• Gene Editing for CEP290-Associated Retinal Degeneration.1 passage
• Gene Therapy in Patients with the Crigler-Najjar Syndrome.1 passage
• Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.1 passage
• Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.1 passage
• Genetically Modified Porcine-to-Human Cardiac Xenotransplantation.1 passage
• Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.1 passage
• Genome Sequencing for Diagnosing Rare Diseases.1 passage
• Genomic Diagnosis of Rare Pediatric Disease in the United Kingdom and Ireland.1 passage
• Germline Mutations in CIDEB and Protection against Liver Disease.1 passage
• Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.1 passage
• Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.25 passages
• Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.1 passage
• Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes.1 passage
• Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.1 passage
• Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.1 passage
• Gout.1 passage
• Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin.33 passages
• Group B Streptococcal Disease.1 passage
• Haloperidol for the Treatment of Delirium in ICU Patients.1 passage
• Health Consequences of Thymus Removal in Adults.1 passage
• Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.1 passage
• Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer.1 passage
• Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy.1 passage
• Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome.1 passage
• Hematopoietic Stem-Cell Gene Therapy for Cystinosis.1 passage
• Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.5 passages
• High-Dose ERT, Rituximab, and Early HSCT in an Infant with Wolman's Disease.1 passage
• High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.1 passage
• High-Dose Influenza Vaccine to Reduce Hospitalizations.1 passage
• High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure.1 passage
• High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality.1 passage
• Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria.2 passages
• Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans.1 passage
• Home-Based Care for Hypertension in Rural South Africa.30 passages
• Homologous and Heterologous Covid-19 Booster Vaccinations.30 passages
• Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.1 passage
• Household Transmission of SARS-CoV-2 from Children and Adolescents.4 passages
• Human Papillomavirus Vaccination.1 passage
• Humoral Innate Immunity and Acute-Phase Proteins.33 passages
• Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.1 passage
• Hydrocortisone in Severe Community-Acquired Pneumonia.1 passage
• Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.1 passage
• Hypertonic Saline or Carbocisteine in Bronchiectasis.1 passage
• Hypothermia or Machine Perfusion in Kidney Donors.1 passage
• Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest.1 passage
• Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial.1 passage
• IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.6 passages
• IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease.1 passage
• Ianalumab plus Eltrombopag in Immune Thrombocytopenia.1 passage
• Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.1 passage
• Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma.1 passage
• Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.1 passage
• Identification of Hepatic-like EPO as a Cause of Polycythemia.1 passage
• Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman's Disease.3 passages
• Imlunestrant with or without Abemaciclib in Advanced Breast Cancer.1 passage
• Immediate "Kangaroo Mother Care" and Survival of Infants with Low Birth Weight.27 passages
• Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction.1 passage
• Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis.1 passage
• Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2.4 passages
• Immunobridging for Pemivibart, a Monoclonal Antibody for Prevention of Covid-19.5 passages
• Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.35 passages
• Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.4 passages
• Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.1 passage
• Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.4 passages
• Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373.3 passages
• Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis.3 passages
• Immunotherapy for MIS-C - IVIG, Glucocorticoids, and Biologics.7 passages
• Implanted System for Orthostatic Hypotension in Multiple-System Atrophy.1 passage
• Implications of Race Adjustment in Lung-Function Equations.1 passage
• Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.1 passage
• Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.1 passage
• In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's Disease.1 passage
• In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6.4 passages
• Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63°C and 72°C.4 passages
• Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer.1 passage
• Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants.1 passage
• Incidence of Scrub Typhus in Rural South India.21 passages
• Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.4 passages
• Increasing Firearm-Related Deaths among U.S. Black Rural Youths.3 passages
• Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.1 passage
• Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias.1 passage
• Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy.1 passage
• Inebilizumab for Treatment of IgG4-Related Disease.1 passage
• Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.4 passages
• Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women.28 passages
• Inflammatory Myopathies.1 passage
• Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.1 passage
• Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.31 passages
• Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.1 passage
• Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.1 passage
• Inhibition of CD40L with Frexalimab in Multiple Sclerosis.1 passage
• Inhibition of Prekallikrein for Hereditary Angioedema.1 passage
• Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment.1 passage
• Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke.1 passage
• Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.1 passage
• Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease.1 passage
• Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.34 passages
• Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.31 passages
• Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup.6 passages
• Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.1 passage
• Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.1 passage
• Intersectional Analysis of U.S. Medical Faculty Diversity over Four Decades.1 passage
• Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.31 passages
• Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.1 passage
• Intraosseous or Intravenous Vascular Access for Out-of-Hospital Cardiac Arrest.1 passage
• Intrathecal Gene Therapy for Giant Axonal Neuropathy.1 passage
• Intravascular Imaging-Guided or Angiography-Guided Complex PCI.1 passage
• Intravascular Ultrasound-Guided or Angiography-Guided Complex High-Risk PCI.1 passage
• Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus.1 passage
• Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors.1 passage
• Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis.25 passages
• Intravenous Tenecteplase before Thrombectomy in Stroke.1 passage
• Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit.1 passage
• Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma.1 passage
• Introduction of Mpox Virus Clade Ib into the Republic of the Congo.3 passages
• Invasive Treatment Strategy for Older Patients with Myocardial Infarction.1 passage
• Iptacopan in IgA Nephropathy - Final 24-Month Data.1 passage
• Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.1 passage
• Ivermectin to Control Malaria - A Cluster-Randomized Trial.1 passage
• Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.1 passage
• JAK Inhibitors - More Than Just Glucocorticoids.6 passages
• Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults.1 passage
• Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.1 passage
• Lecanemab in Early Alzheimer's Disease.1 passage
• Left Atrial Appendage Closure after Ablation for Atrial Fibrillation.1 passage
• Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation.1 passage
• Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation.1 passage
• Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke.1 passage
• Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention.1 passage
• Lentiviral Gene Therapy for Artemis-Deficient SCID.1 passage
• Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy.1 passage
• Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.1 passage
• Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A.25 passages
• Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.1 passage
• Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.1 passage
• Lepodisiran - A Long-Duration Small Interfering RNA Targeting Lipoprotein(a).1 passage
• Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis.1 passage
• Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam.1 passage
• Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.1 passage
• Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid Hemorrhage.1 passage
• Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury.1 passage
• Lifting Universal Masking in Schools - Covid-19 Incidence among Students and Staff.29 passages
• Liquefied Petroleum Gas or Biomass Cooking and Severe Infant Pneumonia.33 passages
• Liquefied Petroleum Gas or Biomass for Cooking and Effects on Birth Weight.1 passage
• Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial.1 passage
• Live Birth with or without Preimplantation Genetic Testing for Aneuploidy.1 passage
• Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.1 passage
• Liver Transplantation in a Woman with Mahvash Disease.1 passage
• Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.1 passage
• Locally Acquired Melioidosis Linked to Environment - Mississippi, 2020-2023.1 passage
• Long Covid Defined.25 passages
• Long Covid and Impaired Cognition - More Evidence and More Work to Do.6 passages
• Long-Term Complications in Youth-Onset Type 2 Diabetes.1 passage
• Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy.1 passage
• Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.23 passages
• Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure.1 passage
• Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia.1 passage
• Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency.1 passage
• Longevity of a Brain-Computer Interface for Amyotrophic Lateral Sclerosis.23 passages
• Longitudinal Changes in Airway Mucus Plugs and FEV1 in COPD.3 passages
• Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension.1 passage
• Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries.34 passages
• Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.1 passage
• Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.1 passage
• Low-Dose Yellow Fever Vaccine in Adults in Africa.29 passages
• Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure.1 passage
• Lower versus Higher Glycemic Criteria for Diagnosis of Gestational Diabetes.1 passage
• Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.1 passage
• Lung Transplantation for Covid-19-Related Respiratory Failure in the United States.3 passages
• Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.1 passage
• MRI-Targeted or Standard Biopsy in Prostate Cancer Screening.1 passage
• Maintaining Safety with SARS-CoV-2 Vaccines.11 passages
• Maintenance or Discontinuation of Antidepressants in Primary Care.1 passage
• Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis.1 passage
• Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical Responses.1 passage
• Mass Administration of Azithromycin to Infants in Mali to Reduce Mortality.1 passage
• Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.26 passages
• Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy.1 passage
• Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.1 passage
• Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.1 passage
• Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma.1 passage
• Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors.1 passage
• Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk.29 passages
• Medical Management and Revascularization for Asymptomatic Carotid Stenosis.1 passage
• Medications for Opioid Use Disorder in County Jails - Outcomes after Release.1 passage
• Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia.27 passages
• Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers.1 passage
• Mental Health Outcomes in Children after Parental Firearm Injury.1 passage
• Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.1 passage
• Methylprednisolone for Heart Surgery in Infants - A Randomized, Controlled Trial.1 passage
• Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.1 passage
• Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.1 passage
• Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.1 passage
• Microvascular Inflammation of Kidney Allografts and Clinical Outcomes.1 passage
• Microvascular Injury in the Brains of Patients with Covid-19.3 passages
• Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma.1 passage
• Mild Hypercapnia or Normocapnia after Out-of-Hospital Cardiac Arrest.1 passage
• Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.1 passage
• Milvexian for the Prevention of Venous Thromboembolism.1 passage
• Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.1 passage
• Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.1 passage
• Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.1 passage
• Mitapivat versus Placebo for Pyruvate Kinase Deficiency.1 passage
• Mitochondrial Donation and Preimplantation Genetic Testing for mtDNA Disease.32 passages
• Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease.18 passages
• Modest Blood Pressure Increase with Age in Adults with Down's Syndrome.4 passages
• Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse Events.5 passages
• Molnupiravir - A Step toward Orally Bioavailable Therapies for Covid-19.5 passages
• Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.31 passages
• Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.1 passage
• Monoclonal Anti-Platelet Factor 4 Antibodies in Recurrent Pregnancy Loss.6 passages
• Monoclonal Antibodies in the Pathogenesis of Heparin-Induced Thrombocytopenia.21 passages
• Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection.7 passages
• Monoclonal Antibodies with Extended Half-Life to Prevent Covid-19.7 passages
• Mortality from Congenital Zika Syndrome - Nationwide Cohort Study in Brazil.23 passages
• Mosquito Net Use in Early Childhood and Survival to Adulthood in Tanzania.1 passage
• Mucormycosis.1 passage
• Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.3 passages
• Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.1 passage
• Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.1 passage
• Multidomain Rehabilitation for Older Patients with Myocardial Infarction.1 passage
• Multidose Ondansetron after Emergency Visits in Children with Gastroenteritis.1 passage
• Multifaceted Strategies for Hypertension Control in Low-Income Patients.31 passages
• Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray.1 passage
• Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.26 passages
• Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.1 passage
• Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A.1 passage
• Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.1 passage
• Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.1 passage
• Myeloma Therapy for Monoclonal Gammopathy of Thrombotic Significance.3 passages
• Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.7 passages
• Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.22 passages
• Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.24 passages
• Myocarditis after Covid-19 mRNA Vaccination.3 passages
• Nasal High-Flow Therapy during Neonatal Endotracheal Intubation.1 passage
• Nationwide, Couple-Based Genetic Carrier Screening.1 passage
• Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules.31 passages
• Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.1 passage
• Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma.1 passage
• Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer.1 passage
• Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.1 passage
• Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.1 passage
• Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.1 passage
• Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.1 passage
• Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer.1 passage
• Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 Years.1 passage
• Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis.1 passage
• Nerandomilast in Patients with Progressive Pulmonary Fibrosis.1 passage
• Neurodevelopmental Disorder Caused by Deletion of CHASERR, a lncRNA Gene.1 passage
• Neuroepithelial Tumor with AAV Integration after Intracisternal Magna Vector Delivery.1 passage
• Neuroprosthesis for Decoding Speech in a Paralyzed Person with Anarthria.1 passage
• Neurovascular Complications of Iatrogenic Fusarium solani Meningitis.1 passage
• Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6.4 passages
• Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.4 passages
• Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection.4 passages
• Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster.5 passages
• Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine.7 passages
• Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines.5 passages
• Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination.3 passages
• Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.3 passages
• Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.4 passages
• Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants.5 passages
• Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum.3 passages
• Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.4 passages
• Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.5 passages
• Neutralizing Activity of BNT162b2-Elicited Serum.4 passages
• Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.14 passages
• Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.3 passages
• New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.1 passage
• New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.7 passages
• Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy.1 passage
• Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.1 passage
• Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.1 passage
• Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.1 passage
• Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge.28 passages
• Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.29 passages
• Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.4 passages
• Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.1 passage
• Nirsevimab and Hospitalization for RSV Bronchiolitis.1 passage
• Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.1 passage
• Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.1 passage
• Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.1 passage
• Nivolumab for Resected Stage III or IV Melanoma at 9 Years.1 passage
• Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.1 passage
• Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.1 passage
• Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.1 passage
• Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.1 passage
• No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.4 passages
• Noninferiority of One HPV Vaccine Dose to Two Doses.1 passage
• Noninvasive Ventilation for Preoxygenation during Emergency Intubation.1 passage
• Nonoperative Management of Mismatch Repair-Deficient Tumors.33 passages
• Nonoperative or Surgical Treatment of Acute Achilles' Tendon Rupture.1 passage
• Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema.1 passage
• Nursing Home Staff Vaccination and Covid-19 Outcomes.4 passages
• Nutritional Support for Moderate-to-Late-Preterm Infants - A Randomized Trial.1 passage
• OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions.1 passage
• Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia.1 passage
• Obesity-Associated GNAS Mutations and the Melanocortin Pathway.1 passage
• Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa.1 passage
• Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.1 passage
• Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.1 passage
• Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.1 passage
• Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis.1 passage
• Omalizumab for the Treatment of Multiple Food Allergies.1 passage
• Omicron - Decoupling Infection from Severe Disease.7 passages
• Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults.5 passages
• Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines.5 passages
• Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.1 passage
• Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.1 passage
• Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.35 passages
• On-Table Reanimation of a Pediatric Heart from Donation after Circulatory Death.1 passage
• Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial.1 passage
• Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes.1 passage
• Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight.1 passage
• Once-Weekly Semaglutide in Adolescents with Obesity.1 passage
• Once-Weekly Semaglutide in Adults with Overweight or Obesity.1 passage
• Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.1 passage
• Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.1 passage
• Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.1 passage
• One Dose versus Three Doses of Benzathine Penicillin G in Early Syphilis.27 passages
• Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.3 passages
• Open-Source Automated Insulin Delivery in Type 1 Diabetes.1 passage
• Optical Coherence Tomography-Guided versus Angiography-Guided PCI.1 passage
• Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents.1 passage
• Oral Infigratinib Therapy in Children with Achondroplasia.1 passage
• Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.1 passage
• Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.29 passages
• Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.27 passages
• Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.1 passage
• Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1.1 passage
• Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.30 passages
• Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.1 passage
• Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.1 passage
• Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity.1 passage
• Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.32 passages
• Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.1 passage
• Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment.1 passage
• Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes.1 passage
• Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC.1 passage
• Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.1 passage
• Outcomes of a Program to Reduce Birth-Related Mortality in Tanzania.1 passage
• Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1.1 passage
• Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.1 passage
• Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.1 passage
• Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.1 passage
• Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.1 passage
• Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer.1 passage
• Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.1 passage
• Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.1 passage
• Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer.1 passage
• Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.1 passage
• Oxygen Targets in Comatose Survivors of Cardiac Arrest.1 passage
• Oxygen-Saturation Targets for Critically Ill Adults Receiving Mechanical Ventilation.1 passage
• Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.1 passage
• PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.1 passage
• PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.1 passage
• PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia.4 passages
• PTH Infusion for Seizures in Autosomal Dominant Hypocalcemia Type 1.2 passages
• Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer.1 passage
• Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors.20 passages
• Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.1 passage
• Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.23 passages
• Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease.1 passage
• Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.1 passage
• Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.1 passage
• Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.1 passage
• Pembrolizumab in HER2-Positive Gastric Cancer.3 passages
• Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.1 passage
• Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.1 passage
• Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.1 passage
• Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer.1 passage
• Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.1 passage
• Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer.1 passage
• Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.1 passage
• Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.1 passage
• Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.1 passage
• Perioperative Nivolumab in Resectable Lung Cancer.1 passage
• Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.1 passage
• Peripheral Artery Disease in the Legs.1 passage
• Permethrin-Treated Baby Wraps for the Prevention of Malaria.25 passages
• Persistent False Positive Covid-19 Rapid Antigen Tests.3 passages
• Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease.1 passage
• Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors.1 passage
• Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid.1 passage
• Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3.1 passage
• Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.1 passage
• Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.1 passage
• Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.1 passage
• Phase 2 Trial of Difelikefalin in Notalgia Paresthetica.1 passage
• Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.1 passage
• Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.35 passages
• Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.1 passage
• Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.1 passage
• Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.27 passages
• Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.1 passage
• Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.1 passage
• Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis.1 passage
• Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.1 passage
• Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.1 passage
• Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.1 passage
• Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.1 passage
• Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.1 passage
• Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.26 passages
• Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge.6 passages
• Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.1 passage
• Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.1 passage
• Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.1 passage
• Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.1 passage
• Physical Rehabilitation for Older Patients Hospitalized for Heart Failure.1 passage
• Physiologic Pacing in Heart Failure.1 passage
• Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.1 passage
• Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.1 passage
• Plasma Neutralization of the SARS-CoV-2 Omicron Variant.5 passages
• Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.1 passage
• Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History.3 passages
• Platform Trials - Beware the Noncomparable Control Group.3 passages
• Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.1 passage
• Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia.1 passage
• Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.1 passage
• Polymyalgia Rheumatica.1 passage
• Polypill Strategy in Secondary Cardiovascular Prevention.1 passage
• Polypill with or without Aspirin in Persons without Cardiovascular Disease.1 passage
• Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.26 passages
• Ponsegromab for the Treatment of Cancer Cachexia.1 passage
• Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.32 passages
• Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease.1 passage
• Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.1 passage
• Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras.29 passages
• Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.1 passage
• Posture, Gait, Quality of Life, and Hearing with a Vestibular Implant.1 passage
• Potential for Maternally Administered Vaccine for Infant Group B Streptococcus.1 passage
• Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.1 passage
• Pre-Covid-19, SARS-CoV-2-Negative Multisystem Inflammatory Syndrome in Children.4 passages
• Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.1 passage
• Prehospital Resuscitation with Type O Whole Blood for Trauma and Hemorrhage.1 passage
• Prehospital Tranexamic Acid for Severe Trauma.1 passage
• Prehospital Whole Blood in Traumatic Hemorrhage - a Randomized Controlled Trial.1 passage
• Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.20 passages
• Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer.30 passages
• Preoperative Chemoradiotherapy for Resectable Gastric Cancer.1 passage
• Preoperative Treatment of Locally Advanced Rectal Cancer.1 passage
• Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.32 passages
• Prime Editing for p47phox-Deficient Chronic Granulomatous Disease.1 passage
• Problems with Using Polygenic Scores to Select Embryos.1 passage
• Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.1 passage
• Proportional-Assist Ventilation for Minimizing the Duration of Mechanical Ventilation.1 passage
• Prospective Memory Assessment before and after Covid-19.5 passages
• Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.1 passage
• Prospective, Multicenter, Controlled Trial of Mobile Stroke Units.1 passage
• Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only.1 passage
• Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua.5 passages
• Protection against Covid-19 by BNT162b2 Booster across Age Groups.25 passages
• Protection against Omicron from Vaccination and Previous Infection in a Prison System.35 passages
• Protection against Reinfection with the Omicron BA.2.75 Subvariant.5 passages
• Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.36 passages
• Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.6 passages
• Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.30 passages
• Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.24 passages
• Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.23 passages
• Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.4 passages
• Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants.5 passages
• Psychosocial Functioning in Transgender Youth after 2 Years of Hormones.1 passage
• Pulmonary Tuberculosis Detection with MiniDock MTB Using Swab Samples.33 passages
• Pulse Oximetry and Skin Tone in Children.3 passages
• Pulse Oximetry for Monitoring Patients with Covid-19 at Home - A Pragmatic, Randomized Trial.4 passages
• Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation.1 passage
• Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation.1 passage
• Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation.1 passage
• REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.35 passages
• REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.35 passages
• RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.1 passage
• RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults.1 passage
• Race, Genetic Ancestry, and Estimating Kidney Function in CKD.1 passage
• Racial Inequality in Prescription Opioid Receipt - Role of Individual Health Systems.1 passage
• Racial Inequality in Receipt of Medications for Opioid Use Disorder.1 passage
• Racial and Ethnic Differences in Bystander CPR for Witnessed Cardiac Arrest.1 passage
• Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease.1 passage
• Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.34 passages
• Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.1 passage
• Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.1 passage
• Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage.1 passage
• Randomized Trial of Fetal Surgery for Moderate Left Diaphragmatic Hernia.24 passages
• Randomized Trial of Fetal Surgery for Severe Left Diaphragmatic Hernia.28 passages
• Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.1 passage
• Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases.28 passages
• Randomized Trial of Vaccines for Zaire Ebola Virus Disease.1 passage
• Randomized Trial of Very Early Medication Abortion.1 passage
• Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.4 passages
• Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection.1 passage
• Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.1 passage
• Rapid Diagnostic Testing for SARS-CoV-2.24 passages
• Rapid Recovery of Donor Hearts for Transplantation after Circulatory Death.1 passage
• Rare Antagonistic Leptin Variants and Severe, Early-Onset Obesity.1 passage
• Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.3 passages
• Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.1 passage
• Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment.5 passages
• Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion.4 passages
• Receipt of mRNA Vaccine against Covid-19 and Myocarditis.5 passages
• Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura.1 passage
• Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura.19 passages
• Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.1 passage
• Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age.1 passage
• Reduction of Antihypertensive Treatment in Nursing Home Residents.1 passage
• Reemergence of Cholera in Haiti.3 passages
• Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.1 passage
• Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma.1 passage
• Remibrutinib in Chronic Spontaneous Urticaria.1 passage
• Removal of Small, Asymptomatic Kidney Stones and Incidence of Relapse.1 passage
• Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.1 passage
• Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.1 passage
• Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.40 passages
• Research in the Context of a Pandemic.5 passages
• Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use.3 passages
• Resolution of Squamous-Cell Carcinoma by Restoring T-Cell Receptor Signaling.16 passages
• Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.1 passage
• Response to PARP Inhibition in BARD1-Mutated Refractory Neuroblastoma.3 passages
• Restriction of Intravenous Fluid in ICU Patients with Septic Shock.1 passage
• Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.1 passage
• Results after Four Years of Screening for Prostate Cancer with PSA and MRI.1 passage
• Results of Two Cases of Pig-to-Human Kidney Xenotransplantation.1 passage
• Resumption of Cardiac Activity after Withdrawal of Life-Sustaining Measures.1 passage
• Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce.5 passages
• Resurgence of Zoonotic Highly Pathogenic Avian Influenza A(H5N1) Virus in Cambodia.3 passages
• Reteplase versus Alteplase for Acute Ischemic Stroke.1 passage
• Revival of Ethionamide by Alpibectir.2 passages
• Ribociclib plus Endocrine Therapy in Early Breast Cancer.1 passage
• Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.1 passage
• Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial.1 passage
• Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.1 passage
• Risdiplam in Presymptomatic Spinal Muscular Atrophy.1 passage
• Risdiplam in Type 1 Spinal Muscular Atrophy.1 passage
• Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls.1 passage
• Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure.1 passage
• Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants.3 passages
• Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.26 passages
• Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.1 passage
• Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.1 passage
• Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia.1 passage
• Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation.1 passage
• Routine Functional Testing or Standard Care in High-Risk Patients after PCI.1 passage
• Routine Spironolactone in Acute Myocardial Infarction.1 passage
• Rucaparib or Physician's Choice in Metastatic Prostate Cancer.1 passage
• Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera.1 passage
• Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.1 passage
• SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.4 passages
• SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.5 passages
• SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.4 passages
• SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.4 passages
• SARS-CoV-2 Infection in Patients with a History of VITT.3 passages
• SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.3 passages
• SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.25 passages
• SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.6 passages
• SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.5 passages
• SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.9 passages
• SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children.4 passages
• SARS-CoV-2 Variants and Vaccines.18 passages
• SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.1 passage
• Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.1 passage
• Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.1 passage
• Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.1 passage
• Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC.1 passage
• Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite.1 passage
• Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.28 passages
• Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.1 passage
• Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.36 passages
• Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.1 passage
• Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali.1 passage
• Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.23 passages
• Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children.28 passages
• Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.32 passages
• Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.1 passage
• Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.31 passages
• Safety of Kidney Transplantation from Donors with HIV.28 passages
• Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.34 passages
• Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.1 passage
• Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.33 passages
• Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.1 passage
• Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention.1 passage
• Second-Line Antiretroviral Therapy for Children Living with HIV in Africa.26 passages
• Second-Line Switch to Dolutegravir for Treatment of HIV Infection.1 passage
• Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.1 passage
• Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.1 passage
• Secondary Prevention after Ischemic Stroke.1 passage
• Selective Decontamination of the Digestive Tract during Ventilation in the ICU.1 passage
• Selective Inhibition of NaV1.8 with VX-548 for Acute Pain.1 passage
• Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus.1 passage
• Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.1 passage
• Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.1 passage
• Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.1 passage
• Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.1 passage
• Sequencing-Based Detection of Avian Influenza A(H5N1) Virus in Wastewater in Ten Cities.4 passages
• Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.1 passage
• Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia.1 passage
• Serogroup Switching in Neisseria meningitidis with Dual Antibiotic Resistance.3 passages
• Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.3 passages
• Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer.1 passage
• Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer.1 passage
• Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab.1 passage
• Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections.4 passages
• Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk.1 passage
• Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.20 passages
• Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.1 passage
• Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.1 passage
• Simvastatin in Critically Ill Patients with Covid-19.32 passages
• Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.1 passage
• Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.26 passages
• Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.1 passage
• Single-Dose Rifapentine in Household Contacts of Patients with Leprosy.1 passage
• Single-Incision Mini-Slings for Stress Urinary Incontinence in Women.1 passage
• Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease.1 passage
• Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.5 passages
• Skin Antisepsis before Surgical Fixation of Extremity Fractures.1 passage
• Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.1 passage
• Snake Envenomation.1 passage
• Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations.1 passage
• Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.1 passage
• Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.1 passage
• Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.1 passage
• Sotatercept for the Treatment of Pulmonary Arterial Hypertension.1 passage
• Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.1 passage
• Sotorasib for Lung Cancers with KRAS p.G12C Mutation.1 passage
• Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation.1 passage
• Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer.1 passage
• Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.1 passage
• Sparing of Severe Covid-19 in Vaccinated Adolescents.5 passages
• Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.1 passage
• Spermatogonium-Derived Complete Hydatidiform Mole.1 passage
• Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults.1 passage
• Spinal Epidural Abscess.1 passage
• Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece.1 passage
• Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England.4 passages
• Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer.21 passages
• Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.1 passage
• Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation.1 passage
• Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.3 passages
• Structured Exercise after Adjuvant Chemotherapy for Colon Cancer.1 passage
• Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.1 passage
• Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.35 passages
• Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD.24 passages
• Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1.4 passages
• Sudden Cardiac Arrest in Athletes.1 passage
• Sudden Cardiac Death and Myocardial Fibrosis, Determined by Autopsy, in Persons with HIV.1 passage
• Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults.1 passage
• Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.1 passage
• Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression.1 passage
• Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.1 passage
• Survival with Cemiplimab in Recurrent Cervical Cancer.1 passage
• Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC.1 passage
• Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.1 passage
• Surviving Covid-19 with Heparin?6 passages
• Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.4 passages
• Susceptibility to Vaccine-Preventable Infections in Asylum Seekers.3 passages
• Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B.15 passages
• Sutimlimab in Cold Agglutinin Disease.1 passage
• Systemic Inflammation and Normocytic Anemia in DOCK11 Deficiency.1 passage
• T-Cell Neoplasms after B-Cell Neoplasms - The Pre-CAR T-Cell Era.3 passages
• Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma.1 passage
• Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma.1 passage
• Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy.4 passages
• Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.1 passage
• Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.1 passage
• Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.1 passage
• Teclistamab in Relapsed or Refractory Multiple Myeloma.1 passage
• Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.1 passage
• Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo.30 passages
• Tecovirimat for Monkeypox in Central African Republic under Expanded Access.3 passages
• Tecovirimat for the Treatment of Mpox.1 passage
• Telitacicept for IgA Nephropathy - Interim Analysis of a Phase 3 Trial.1 passage
• Ten-Year Outcomes after Bariatric Surgery in Adolescents.3 passages
• Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer.29 passages
• Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy.1 passage
• Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection.1 passage
• Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes.1 passage
• Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.1 passage
• Testosterone Treatment and Fractures in Men with Hypogonadism.1 passage
• Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.1 passage
• Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps.1 passage
• Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia.1 passage
• The Duration of Immunotherapy for Mismatch Repair-Deficient Cancers.2 passages
• The Genetic Architecture of Congenital Diarrhea and Enteropathy.17 passages
• The Goldilocks Time for Remdesivir - Is Any Indication Just Right?5 passages
• The IARC Perspective on the Effects of Policies on Reducing Alcohol Consumption.17 passages
• The Importance of Context in Covid-19 Vaccine Safety.7 passages
• The Inherited Basis of Coronary Artery Disease.1 passage
• The Potential of Intentional Drug Development.6 passages
• The RECOVERY Platform.5 passages
• The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1.1 passage
• The Safety of Inpatient Health Care.1 passage
• The Vaccine-Hesitant Moment.17 passages
• Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.29 passages
• Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.29 passages
• Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.6 passages
• Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents.1 passage
• Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.3 passages
• Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients.4 passages
• Three Cases of Vertical Transmission of Clade Ib Mpox Virus.3 passages
• Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.3 passages
• Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage.1 passage
• Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.1 passage
• Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study.3 passages
• Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.19 passages
• Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer.4 passages
• Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.5 passages
• Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.19 passages
• Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.1 passage
• Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome.1 passage
• Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA.1 passage
• Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU.1 passage
• Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.1 passage
• Timing of Primary Surgery for Cleft Palate.1 passage
• Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion.1 passage
• Tirzepatide Once Weekly for the Treatment of Obesity.1 passage
• Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.1 passage
• Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.1 passage
• Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.1 passage
• Tirzepatide for Obesity Treatment and Diabetes Prevention.1 passage
• Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.1 passage
• Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.1 passage
• Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.1 passage
• Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.30 passages
• Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.30 passages
• Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.28 passages
• Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis.1 passage
• Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.1 passage
• Total Hip Replacement or Resistance Training for Severe Hip Osteoarthritis.1 passage
• Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19.3 passages
• Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom.5 passages
• Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery.1 passage
• Tranexamic Acid in Patients Undergoing Noncardiac Surgery.1 passage
• Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery.1 passage
• Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis.1 passage
• Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years.1 passage
• Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia.1 passage
• Transcatheter Repair for Patients with Tricuspid Regurgitation.1 passage
• Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation.1 passage
• Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation.1 passage
• Transcatheter Valve Replacement in Severe Tricuspid Regurgitation.1 passage
• Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.1 passage
• Transcatheter or Surgical Treatment of Aortic-Valve Stenosis.1 passage
• Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.1 passage
• Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes.1 passage
• Transmission as a Key Driver of Resistance to the New Tuberculosis Drugs.3 passages
• Transplantation Outcomes with Donor Hearts after Circulatory Death.1 passage
• Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.1 passage
• Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.1 passage
• Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.1 passage
• Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer.1 passage
• Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer.1 passage
• Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer.1 passage
• Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.1 passage
• Treating Acute Covid-19 - Final Chapters Still Unwritten.7 passages
• Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest.1 passage
• Treatment Strategy for Rifampin-Susceptible Tuberculosis.33 passages
• Treatment for Mild Chronic Hypertension during Pregnancy.1 passage
• Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.1 passage
• Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy.1 passage
• Treatment of Multisystem Inflammatory Syndrome in Children.33 passages
• Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells.1 passage
• Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.1 passage
• Treatment-Resistant Depression in Older Adults.1 passage
• Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018.1 passage
• Trends in Youth-Onset Type 2 Diabetes, 2013-2024.3 passages
• Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.1 passage
• Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.1 passage
• Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.1 passage
• Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.1 passage
• Trial of Botulinum Toxin for Isolated or Essential Head Tremor.1 passage
• Trial of Cinpanemab in Early Parkinson's Disease.1 passage
• Trial of Deferiprone in Parkinson's Disease.1 passage
• Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage.1 passage
• Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.1 passage
• Trial of Endovascular Thrombectomy for Large Ischemic Strokes.1 passage
• Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion.1 passage
• Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.1 passage
• Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease.1 passage
• Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis.31 passages
• Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.1 passage
• Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.1 passage
• Trial of Intravenous Immune Globulin in Dermatomyositis.1 passage
• Trial of Lixisenatide in Early Parkinson's Disease.1 passage
• Trial of N-Acetyl-l-Leucine in Niemann-Pick Disease Type C.1 passage
• Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.1 passage
• Trial of Pimavanserin in Dementia-Related Psychosis.1 passage
• Trial of Prasinezumab in Early-Stage Parkinson's Disease.1 passage
• Trial of Psilocybin versus Escitalopram for Depression.1 passage
• Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen.26 passages
• Trial of Solanezumab in Preclinical Alzheimer's Disease.1 passage
• Trial of Spesolimab for Generalized Pustular Psoriasis.1 passage
• Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication.24 passages
• Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion.1 passage
• Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size.1 passage
• Trial of Training to Reduce Driver Inattention in Teens with ADHD.1 passage
• Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis.1 passage
• Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty.1 passage
• Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis.1 passage
• Trial of an Intervention to Improve Acute Heart Failure Outcomes.1 passage
• Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons.1 passage
• Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.1 passage
• Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.1 passage
• Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.1 passage
• Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.1 passage
• Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.1 passage
• Tumor-Infiltrating Clonal Hematopoiesis.36 passages
• Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.1 passage
• Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype.1 passage
• Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.1 passage
• Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.1 passage
• Two Phase 3 Trials of Baricitinib for Alopecia Areata.1 passage
• Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.1 passage
• Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.1 passage
• Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.1 passage
• Two Randomized Trials of Low-Dose Calcium Supplementation in Pregnancy.30 passages
• Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.1 passage
• Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.1 passage
• Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media.1 passage
• Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.1 passage
• Ultrasonography or Radiography for Suspected Pediatric Distal Forearm Fractures.1 passage
• Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer's Disease.1 passage
• Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.1 passage
• Understanding Vaccine Safety and the Roles of the FDA and the CDC.18 passages
• Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia.1 passage
• Universal Masking Policies in Schools and Mitigating the Inequitable Costs of Covid-19.6 passages
• Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.1 passage
• Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026.1 passage
• VITT and Second Doses of Covid-19 Vaccine.2 passages
• VITT-like Monoclonal Gammopathy of Thrombotic Significance.1 passage
• VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.30 passages
• Vaccine Breakthrough Infections with SARS-CoV-2 Variants.17 passages
• Vaccine Effectiveness Studies in the Field.7 passages
• Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.1 passage
• Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.1 passage
• Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.35 passages
• Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine.3 passages
• Vaccine-Induced Thrombocytopenia with Severe Headache.4 passages
• Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.1 passage
• Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants.1 passage
• Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.1 passage
• Variant PNLDC1, Defective piRNA Processing, and Azoospermia.1 passage
• Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome.1 passage
• Vedolizumab for the Treatment of Chronic Pouchitis.1 passage
• Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.1 passage
• Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer.1 passage
• Video versus Direct Laryngoscopy for Tracheal Intubation of Critically Ill Adults.1 passage
• Video versus Direct Laryngoscopy for Urgent Intubation of Newborn Infants.1 passage
• Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.4 passages
• Viral Lineages in the 2022 RSV Surge in the United States.3 passages
• Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.1 passage
• Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.1 passage
• Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.30 passages
• Waning Immunity after the BNT162b2 Vaccine in Israel.23 passages
• Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.4 passages
• Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.30 passages
• Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy.1 passage
• Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin.1 passage
• Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B.1 passage
• Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease.1 passage
• Year 1 of the Bundled Payments for Care Improvement-Advanced Model.1 passage
• Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.1 passage
• Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.1 passage
• Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection.1 passage
• Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia.1 passage
• Zongertinib in Previously Treated HER2-Mutant Non-Small-Cell Lung Cancer.1 passage
• Zorevunersen in Children and Adolescents with Dravet Syndrome.1 passage
• ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.1 passage
• mRNA Covid-19 Vaccines in Pregnant Women.6 passages